Palabras clave
embarazo
biomarcadores
macrosomía
insulina
Cómo citar
Resumen
El sobrepeso y la obesidad durante el embarazo incrementan significativamente los riesgos obstétricos, impactando en la prematuridad y en la morbimortalidad materna y perinatal. Estas condiciones afectan la programación fetal, lo que puede llevar al desarrollo de enfermedades metabólicas y neuropsiquiátricas en la descendencia. Este trabajo recopila información para la comprensión de estos riesgos y promueva la implementación de medidas preventivas y terapéuticas desde etapas tempranas. Se han identificado desregulaciones en biomarcadores como insulina, péptido C, leptina, adiponectina e IGF-1, que pueden servir como indicadores de riesgo en mujeres con sobrepeso u obesidad. Promover hábitos saludables durante el embarazo junto con un seguimiento endocrinológico y metabólico es fundamental para interrumpir el ciclo intergeneracional de la obesidad y mejorar la salud de futuras generaciones.
Citas
American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. 2021; 116:1266-1285 [Disponible en: https://www.asrm.org/globalassets/_asrm/practice-guidance/practice-guidelines/pdf/obesity_and_reproduction.pdf][Último acceso: 26/12/2025]
Organización Panamericana de la Salud. Más que una cuestión de peso. 2024. [Disponible en: https://www.paho.org/es/noticias/7-3-2024-mas-que-cuestion-peso][Último acceso: 26/12/2025]
Ministerio de Salud y Desarrollo Social. 4ta Encuesta Nacional de Factores de Riesgo. Dirección Nacional de Promoción de la Salud y Control de Enfermedades Crónicas no Transmisibles, 2019. [Disponible en: https://www.argentina.gob.ar/sites/default/files/bancos/2020-01/4ta-encuesta-nacional-factores-riesgo_2019_informe-definitivo.pdf][Último acceso: 26/12/2025]
World Obesity Federation. Global Obesity Observatory. World Obesity Atlas 2024. [Disponible en: https://data.worldobesity. org/publications/?cat=22][Último acceso: 26/12/2025]
Faa G, Fanos V, Manchia M, Van Eyken P, Suri JS, Saba L. The fascinating theory of fetal programming of adult diseases: A review of the fundamentals of the Barker hypothesis. J Public Health Res. 2024 Mar 1;13(1):22799036241226817. doi: 10.1177/22799036241226817. PMID: 38434579; PMCID: PMC10908242.
Johns EC, Denison FC, Reynolds RM. The impact of maternal obesity in pregnancy on placental glucocorticoid and macronutrient transport and metabolism. Biochim Biophys Acta Mol Basis Dis. 2020;1866(2):165374. doi: 10.1016/j.bbadis.2018.12.025.
Kelly AC, Powell TL, Jansson T. Placental function in maternal obesity. Clin Sci (Lond). 2020; 134:961-984. doi:10.1042/CS20190266.
Zhang CXW, Candia AA, Sferruzzi-Perri AN. Placental inflammation, oxidative stress, and fetal outcomes in maternal obesity. Trends Endocrinol Metab. 2024: S1043-2760(24)00031-6. doi: 10.1016/j.tem.2024.02.002
Napso T, Yong HEJ, Lopez-Tello J, Sferruzzi-Perri AN. The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation. Front Physiol. 2018; 9:1091. doi: 10.3389/fphys.2018.01091.
Sun Y, Shen Z, Zhan Y, Wang Y, Ma S, Zhang S et al. Effects of pre-pregnancy body mass index and gestational weight gain on maternal and infant complications. Pregnancy Childbirth.
; 20:390. doi: 10.1186/s12884-020-03071-y. 11 Monod C, Kotzaeridi G, Linder T, Yerlikaya-Schatten G, Wegener S, Mosimann B et al. Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study. Acta Obstet Gynecol Scand. 2024; 103:257-265. doi: 10.1111/aogs.14688.
Akinmola OO, Okusanya BO, Olorunfemi G, Okpara HC, Azinge EC. Fetal macrosomia, fetal insulin, and insulin- like growth factor- 1 among neonates in Lagos, Nigeria: A case-control study. PLoS One. 2022; 17:0266314. doi: 10.1371/journal.pone.0266314.
Bandres-Meriz J, Dieberger AM, Hoch D, Pöchlauer C, Bachbauer M, Glasner A et al. Maternal obesity affects the glucose- insulin axis during the first trimester of human pregnancy. Front Endocrinol.2020; 11:566673. doi: 10.3389/fendo.2020.566673.
Castillo-Castrejon M, Jansson T, Powell TL. No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus. Am J Physiol Endocrinol Metab. 2019; 317:1037-1049. doi: 10.1152/ajpendo.00196.2019.
Tanirowski PJ, Szukiewicz D, Majewska A, Wątroba M, Pyzlak
M, Bomba-Opoń D et al. Differential expression of glucose transporter proteins GLUT-1, GLUT-3, GLUT-8 and GLUT-12 in the placenta of macrosomic, small-for-gestational-age and growth-restricted foetuses. J Clin Med. 2021; 10:5833. DOI: 10.3390/jcm10245833.
Nogues P, Dos Santos E, Couturier-Tarrade A, Berveiller P, Arnould L, Lamy E et al. Maternal obesity influences placental nutrient transport, inflammatory status, and morphology in human term placenta. J Clin Endocrinol Metab. 2021; 106:1880-1896. doi: 10.1210/clinem/dgaa660.
Dumolt JH, Rosario FJ, Kramer AC, Horwitz S, Powell TL, Jansson T. Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity. Clin Sci (Lond). 2023; 137:663-678. doi: 10.1042/CS20220890.
Niknam A, Ramezani Tehrani F, Behboudi-Gandevani S, Rahmati M, Hedayati M, Abedini M et al. Umbilical cord blood concentration of connecting peptide (C-peptide) and pregnancy outcomes. Pregnancy Childbirth. 2022; 22:764. doi: 10.1186/s12884-022-05081-4.
Khant Aung Z, Grattan DR, Ladyman SR. Pregnancy-induced adaptation of central sensitivity to leptin and insulin. Mol Cell Endocrinol. 2020; 516:11093. doi: 10.1016/j.mce.2020.110933.
Izquierdo AG, Crujeiras AB, Casanueva FF, Carreira MC. Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients. 2019; 11:2704. doi: 10.3390/nu11112704.
Beneventi F, Locatelli E, De Amici M, Cavagnoli C, Bellingeri C, De Maggio I et al. Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia. J Matern Fetal Neonatal Med. 2020; 33:3942-3948. doi: 10.1080/14767058.2019.1593359.
Fonseca DGM, Souza-Carmo M-CN, Ruas RN, Pereira SS, Teixeira LG, Alvarez-Leite EJI. El papel potencial de la leptina en la regulación del peso materno durante el embarazo y su impacto en el peso y el Apgar del neonato. Obesities. 2024; 4:24-34. doi: 10.3390/obesities4010003.
Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013; 34:205-11. doi: 10.1016/j.placenta.2012.11.035.
Telschow A, Ferrari N, Deibert C, Flöck A, Merz WM, Gembruch U et al. High maternal and low cord blood leptin are associated with BMI-SDS gain in the first year of life. Obes Facts. 2019; 12:575-585. doi: 10.1159/000502421.
Nunes M, Da Silva CH, Bosa VL, Bernardi JR, Werlang ICR, Goldani MZ. Could a remarkable decrease in leptin and insulin levels from colostrum to mature milk contribute to early growth catch-up of SGA infants? Pregnancy Childbirth. 2017; 17:410. doi:10.1186/s12884-017-1593-0.
Cordner ZA, Khambadkone SG, Boersma GJ, Song L, Summers TN, Moran TH et al. Maternal high-fat diet results in cognitive impairment and hippocampal gene expression changes in rat offspring. Exp Neurol. 2019; 318:92-100.
doi:10.1016/j.expneurol.2019.04.018.
Glendining KA, Higgins MBA, Fisher LC, Jasoni CL. Maternal obesity modulates sexually dimorphic epigenetic regulation and expression of leptin receptor in offspring hippocampus. Brain Behav Immun. 2020;88:151-160. doi: 10.1016/j.bbi.2020.03.006.
Flores-Dorantes MT, Díaz-López YE, Gutiérrez-Aguilar R. Environment and gene association with obesity and their impact on neurodegenerative and neurodevelopmental diseases. Front Neurosci. 2020 28;14:863. doi:10.3389/fnins.2020.00863
Aye ILMH, Rosario FJ, Kramer A, Kristiansen O, Michelsen TM, Powell TL et al. Insulin increases adipose adiponectin in pregnancy by inhibiting ubiquitination and degradation: impact of obesity. J Clin Endocrinol Metab. 2022; 107:53-66. doi: 10.1210/clinem/dgab680.
Moyce Gruber BL, Cole LK, Xiang B, Fonseca MA, Klein J, Hatch GM et al. Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice. Diabetología. 2022; 65:733-747. doi: 10.1007/s00125-021-05649-3.
Abraham T, Romani AMP. The relationship between obesity and pre-eclampsia: incidental risks and identification of potential biomarkers for pre-eclampsia. Cells. 2022; 11:1548. doi: 10.3390/cells11091548.
Paulsen ME, Rosario FJ, Wesolowski SR, Powell TL, Jansson T. Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring. FASEB J. 2019; 33:2899-2909. doi: 10.1096/fj.201801015R.
Nogues P, Dos Santos E, Jammes H, Berveiller P, Arnould L, Vialard F, Dieudonné MN. Maternal obesity influences expresión and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta. Clin Epigenetics. 2019 Feb 7;11(1):20. doi: 10.1186/s13148-019-0612-6.
Sibiak R, Jankowski M, Gutaj P, Mozdziak P, Kempisty B, Wender-Ożegowska E. Placental actogen as a marker of maternal obesity, diabetes, and fetal growth abnormalities: current knowledge and clinical perspectives. J Clin Med. 2020;
:1142. doi: 10.3390/jcm9041142.
Cattini PA, Jin Y, Jarmasz JS, Noorjahan N, Bock ME. Obesity and regulation of human placental lactogen production in pregnancy. J Neuroendocrinol. 2020; 32:e12859. doi: 10.1111/jne.12859.
Rassie K, Giri R, Joham AE, Teede H, Mousa A. Human placental lactogen in relation to maternal metabolic health and fetal outcomes: A systematic review and meta-analysis. Int J Mol Sci. 2022; 23:15621. doi: 10.3390/ijms232415621.
Moazzam S, Noorjahan N, Jin Y, Nagy JI, Kardami E, Cattini PA. Effect of high fat diet on maternal behavior, brain-derived neurotrophic factor and neural stem cell proliferation in mice expressing human placental lactogen during pregnancy. J Neuroendocrinol. 2024; 12:13258. doi: 10.1111/jne.13258.
Hjelholt A, Høgild M, Bak AM, Arlien-Søborg MC, Bæk A, Jessen N et al. Growth hormone and obesity. Endocrinol Metab Clin North Am. 2020; 49:239-250. doi:10.1016/j.ecl.2020.02.009.
Chen KY, Lin SY, Lee CN, Wu HT, Kuo CH, Kuo HC et al. Maternal plasma lipids during pregnancy, insulin-like Growth Factor-1, and excess fetal growth. J Clin Endocrinol Metab. 2021; 106:3461-3472. DOI: 10.1210/clinem/dgab364.
Castro-Rodriguez JA, Padilla O, Casanello P, Forno E. Higher levels of insulin-like growth factor-1 in cord blood associate with risk of asthma at age 3. Pediatr Pulmonol. 2024; 59:482-487. doi: 10.1002/ppul.26780.
Zhang CXW, Candia AA, Sferruzzi-Perri AN. Placental inflammation, oxidative stress, and fetal outcomes in maternal obesity. Trends Endocrinol Metab. 2024. doi: 10.1016/j.tem.2024.02.002.
Louwen, F, Kreis N, Ritter A, Yuan J. Maternal obesity and placental function: impaired maternal-fetal axis. Archives of gynecology and obstetrics. 2024; 309:2279–2288. doi:10.1007/s00404-024-07462-w.
Muhammad T, Wan Y, Lv Y, et al. Maternal obesity: A potential disruptor of female fertility and current interventions to reduce associated risks. Obes Rev. 2023;24:e13603. doi: 10.1111/obr.13603.
Abraham T, Romani AMP. The Relationship between Obesity and Pre-Eclampsia: Incidental Risks and Identification of Potential Biomarkers for Pre-Eclampsia. Cells, 2022; 11:1548. doi: 10.3390/cells11091548.
Laskewitz A, van Benthem KL, Kieffer TEC, Faas MM, Verkaik-Schakel RN, Plösch T et al. The influence of maternal obesity on macrophage subsets in the human decidua. Cell Immunol. 2019;336:75-82. doi: 10.1016/j.cellimm.2019.01.002.
Josefson JL, Scholtens DM, Kuang A, Catalano PM, Lowe LP, Dyer AR et al. Newborn adiposity and cord blood C-Peptide as mediators of the maternal metabolic environment and childhood adiposity. Diabetes Care. 2021; 44:1194-1202. DOI: 10.2337/dc20-2398.
Pheiffer C, Dias S, Jack B, Malaza N, Adam S. Adiponectin as a Potential Biomarker for Pregnancy Disorders. Int J Mol Sci.2021; 22:1326. DOI: 10.3390/ijms22031326.
Wang C, Liu M, Yan J, Ning J, Wang S, Yang H. Epigenetic effects of exercise on improving the adverse placental environment associated with maternal overweight and obesity. Placenta. 2024 Dec;158:329-337. doi: 10.1016/j.placenta.2024.10.018.
Dearden L, Ozanne SE. Early life impacts of maternal obesity: a window of opportunity to improve the health of two generations. Philos Trans R Soc Lond B Biol Sci. 2023; 378:20220222. doi: 10.1098/rstb.2022.0222.
De Cuevillas B, Milagro FI, Tur JA, Gil-Campos M, De Miguel-Etayo P, Martínez JA et al. Fecal microbiota relationships with childhood obesity: A scoping comprehensive review. Obes Rev. 2022; 23:e13394. doi:10.1111/obr.13394.51 Tekin Guler T, Koc N, Kara Uzun A, Fisunoglu M. The association of pre-pregnancy BMI on leptin, ghrelin, adiponectin and insulin-like growth factor-1 in breast milk: a case-control study. Br J Nutr. 2022;127:1675-1681. doi:10.1017/S0007114521002932.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2026 Revista Sociedad Argentina de Endocrinología Ginecológica y Reproductiva